Comments
Natco Pharma Ltd has received approval from the US Food and Drug Administration for its Abbreviated New Drug Application for Lansoprazole Delayed Release Capsules for the prescription market.
The drug is indicated for the treatment of gastric (stomach) ulcers. Shipments of this product will commence immediately, the Hyderabad-based company said in a release.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.